David Hangauer

2.5k total citations
64 papers, 2.0k citations indexed

About

David Hangauer is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, David Hangauer has authored 64 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 17 papers in Oncology and 16 papers in Organic Chemistry. Recurrent topics in David Hangauer's work include Protein Structure and Dynamics (16 papers), Chemical Synthesis and Analysis (15 papers) and Computational Drug Discovery Methods (9 papers). David Hangauer is often cited by papers focused on Protein Structure and Dynamics (16 papers), Chemical Synthesis and Analysis (15 papers) and Computational Drug Discovery Methods (9 papers). David Hangauer collaborates with scholars based in United States, Germany and South Korea. David Hangauer's co-authors include G. Klebe, A. Heine, Brian W. Matthews, A.F. Monzingo, Bernhard Baum, Michael Smolinski, J. Biela, W. J. GREENLEE, Mohamed F. Zayed and Michael Betz and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

David Hangauer

64 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Hangauer United States	27	1.3k	524	353	350	207	64	2.0k
Roberto Battistutta Italy	31	2.1k 1.6×	414 0.8×	369 1.0×	322 0.9×	353 1.7×	69	3.1k
Brian Dymock Singapore	30	1.8k 1.4×	553 1.1×	513 1.5×	502 1.4×	127 0.6×	78	2.9k
James R. Kiefer United States	21	1.2k 1.0×	691 1.3×	410 1.2×	255 0.7×	137 0.7×	40	2.7k
Yuk Y. Sham United States	31	2.2k 1.7×	625 1.2×	293 0.8×	182 0.5×	362 1.7×	85	3.2k
Ralf Thoma Switzerland	23	1.3k 1.1×	329 0.6×	297 0.8×	171 0.5×	416 2.0×	33	2.3k
Chung F. Wong United States	24	1.4k 1.1×	213 0.4×	149 0.4×	460 1.3×	306 1.5×	86	2.0k
Annick Dejaegere France	27	1.4k 1.1×	432 0.8×	174 0.5×	146 0.4×	206 1.0×	72	2.2k
Martin J. Drysdale United Kingdom	30	2.1k 1.6×	704 1.3×	171 0.5×	664 1.9×	224 1.1×	61	2.9k
Bernard Gsell Switzerland	17	907 0.7×	302 0.6×	200 0.6×	133 0.4×	244 1.2×	19	1.7k
Renée L. DesJarlais United States	28	1.5k 1.2×	727 1.4×	264 0.7×	768 2.2×	230 1.1×	61	2.5k

Countries citing papers authored by David Hangauer

Since Specialization

Citations

This map shows the geographic impact of David Hangauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hangauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hangauer more than expected).

Fields of papers citing papers by David Hangauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hangauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hangauer. The network helps show where David Hangauer may publish in the future.

Co-authorship network of co-authors of David Hangauer

This figure shows the co-authorship network connecting the top 25 collaborators of David Hangauer. A scholar is included among the top collaborators of David Hangauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hangauer. David Hangauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kasner, Margaret, Molly B. Halloran, Ellen K. Ritchie, et al.. (2022). A phase Ib dose escalation study of oral monotherapy with KX2-391 in elderly patients with acute myeloid leukemia. Investigational New Drugs. 40(4). 773–781. 3 indexed citations

Smolinski, Michael, Yahao Bu, James L. Clements, et al.. (2018). Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361). Journal of Medicinal Chemistry. 61(11). 4704–4719. 72 indexed citations

Anbalagan, Muralidharan, Yifang Zhang, Yuanjun Gao, et al.. (2017). Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression. Molecular Cancer Research. 15(11). 1491–1502. 13 indexed citations

Kim, Seongyeong, Ahrum Min, Kyung-Hun Lee, et al.. (2016). Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis. Cancer Research and Treatment. 49(3). 643–655. 26 indexed citations

Naing, Aung, Roger B. Cohen, Grace K. Dy, et al.. (2013). A phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies. Investigational New Drugs. 31(4). 967–973. 26 indexed citations

Anbalagan, Muralidharan, Alaa M. Ali, Ryan K. Jones, et al.. (2012). Peptidomimetic Src/Pretubulin Inhibitor KX-01 Alone and in Combination with Paclitaxel Suppresses Growth, Metastasis in Human ER/PR/HER2-Negative Tumor Xenografts. Molecular Cancer Therapeutics. 11(9). 1936–1947. 39 indexed citations

Biela, J., Maan T. Khayat, Hongwei Tan, et al.. (2012). Impact of Ligand and Protein Desolvation on Ligand Binding to the S1 Pocket of Thrombin. Journal of Molecular Biology. 418(5). 350–366. 44 indexed citations

Foroumadi, Alireza, Rakesh Kumar Tiwari, Amir Nasrolahi Shirazi, et al.. (2011). Thiazolyl N-benzyl-substituted acetamide derivatives: Synthesis, Src kinase inhibitory and anticancer activities. European Journal of Medicinal Chemistry. 46(10). 4853–4858. 57 indexed citations

Bielefeld, Eric C., David Hangauer, & Donald Henderson. (2011). Protection from impulse noise-induced hearing loss with novel Src-protein tyrosine kinase inhibitors. Neuroscience Research. 71(4). 348–354. 12 indexed citations

10.

Baum, Bernhard, et al.. (2010). Non-additivity of Functional Group Contributions in Protein–Ligand Binding: A Comprehensive Study by Crystallography and Isothermal Titration Calorimetry. Journal of Molecular Biology. 397(4). 1042–1054. 127 indexed citations

11.

Baum, Bernhard, Mohamed F. Zayed, Christof Gerlach, et al.. (2009). More than a Simple Lipophilic Contact: A Detailed Thermodynamic Analysis of Nonbasic Residues in the S1 Pocket of Thrombin. Journal of Molecular Biology. 390(1). 56–69. 104 indexed citations

12.

Hangauer, David, et al.. (2007). Potent and selective in vitro and in vivo inhibition of tumor proliferation by KXO1, a novel non-ATP competitive Src inhibitor. Cancer Research. 67. 3245–3245. 7 indexed citations

13.

Gerlach, Christof, Michael Smolinski, H. Steuber, et al.. (2007). Thermodynamic Inhibition Profile of a Cyclopentyl and a Cyclohexyl Derivative towards Thrombin: The Same but for Different Reasons. Angewandte Chemie International Edition. 46(44). 8511–8514. 28 indexed citations

14.

Harris, Kelly C., Bohua Hu, David Hangauer, & Donald Henderson. (2005). Prevention of noise-induced hearing loss with Src-PTK inhibitors. Hearing Research. 208(1-2). 14–25. 43 indexed citations

15.

Pruitt, Steven C., et al.. (2004). Privileged scaffolds for blocking protein–protein interactions: 1,4-disubstituted naphthalene antagonists of transcription factor complex HOX–PBX/DNA. Bioorganic & Medicinal Chemistry Letters. 14(15). 3875–3879. 10 indexed citations

16.

Kim, Taek Hyeon & David Hangauer. (2000). Polymer-bound Boronate via the Solid Phase Coupling Reaction of Resin-bound Aryl Triflate with Diboron Pinacol Ester. Bulletin of the Korean Chemical Society. 21(8). 757–758. 2 indexed citations

17.

Marsilje, Thomas H., Karen L. Milkiewicz, & David Hangauer. (2000). The design, synthesis and activity of non-ATP competitive inhibitors of pp60c-src tyrosine kinase.Part 1: Hydroxynaphthalene derivatives. Bioorganic & Medicinal Chemistry Letters. 10(5). 477–481. 23 indexed citations

18.

Milkiewicz, Karen L., et al.. (2000). The design, synthesis and activity of non-ATP competitive inhibitors of pp60c-src tyrosine kinase. Part 2: Hydroxyindole derivatives. Bioorganic & Medicinal Chemistry Letters. 10(5). 483–486. 29 indexed citations

19.

Pavia, Michael R., Michael P. Cohen, Tracy Durgin, et al.. (1996). The design and synthesis of substituted biphenyl libraries. Bioorganic & Medicinal Chemistry. 4(5). 659–666. 37 indexed citations

20.

Saperstein, Richard, Pasquale P. Vicario, H.V. Strout, et al.. (1989). Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells. Biochemistry. 28(13). 5694–5701. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact